Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 20, 2026

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

[Extrapulmonary small cell carcinoma in 52 patients].

Zhong-Yu Yuan1, Zhong-Zhen Guan, Zhong-Mei Zhou

  • 1State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, 510060, P. R. China. oncoloyzy2000@163.com

AI Zheng = Aizheng = Chinese Journal of Cancer
|September 13, 2006
PubMed
Summary

Extrapulmonary small cell carcinoma (ESCC) occurs in various sites, most commonly the esophagus. Limited disease-ESCC shows a significantly better prognosis than extensive disease-ESCC, with multimodality therapy being key.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ketone Body Metabolism and Sodium Glucose Cotransporter 2 Inhibitor Response in Heart Failure With Ischemic Cause: A Precision Medicine Approach Using Metabolomics Integration With Global Burden of Disease Population Data Across Diverse Genetic Backgrounds.

Journal of the American Heart Association·2026
Same author

First Comparative Evaluation of TyG-ABSI Versus Traditional TyG-Related Indices for Cardiovascular Disease and Mortality Prediction in Hypertensive Patients: TyG-ABSI Versus Traditional TyG-Related Indices.

Journal of clinical hypertension (Greenwich, Conn.)·2026
Same author

Synergistic effects of hypertension and diabetes on cardiovascular risk in elderly: Comparative longitudinal analysis of CHARLS and HRS.

Diabetes, obesity & metabolism·2026
Same author

USP16 S-nitrosylation aggravates coronary microembolization-induced myocardial injury via repressing KDM1A-mediated glutathione homeostasis.

Nature communications·2025
Same author

Prevalence of coexisting diabetes and depression and the association of urinary albumin with all-cause and cardiovascular mortality in affected individuals: a National population-based study.

Diabetology & metabolic syndrome·2025
Same author

Synthesis of Magnetically Modified Copper-Based Metal-Organic Frameworks for Cellulose Hydrolysis.

ACS omega·2025

Area of Science:

  • Oncology
  • Pathology
  • Clinical Medicine

Context:

  • Extrapulmonary small cell carcinoma (ESCC) is a distinct clinicopathologic entity.
  • ESCC predominantly affects the lung but can arise in various extrathoracic sites.
  • Understanding ESCC's characteristics is crucial for effective management.

Purpose:

  • To investigate the clinical characteristics of ESCC.
  • To analyze therapeutic approaches for ESCC.
  • To determine the prognostic factors influencing ESCC patient outcomes.

Summary:

  • A retrospective analysis of 53 ESCC patients (1985-2005) revealed the esophagus as the most common primary site (62.3%).
  • Limited disease (LD-ESCC) patients (75.5%) received diverse treatments including surgery, radiotherapy, and chemotherapy, while extensive disease (ED-ESCC) patients primarily received platinum-based chemotherapy.

More Related Videos

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Related Experiment Videos

Last Updated: Jul 20, 2026

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

  • Median survival time was 20 months overall, with LD-ESCC patients demonstrating significantly better survival (26 months) compared to ED-ESCC patients (15 months).

    • Impact:

    • ESCC presents diverse clinical features and primary sites, with the esophagus being most frequent.
    • Multimodality therapy is increasingly utilized for LD-ESCC, while combination chemotherapy is standard for ED-ESCC.
    • Prognosis is significantly better for LD-ESCC than ED-ESCC, highlighting the importance of disease extent in treatment planning and outcomes.